Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Administration Unveils Transparency Initiatives; Private Sector Follows Suit

This article was originally published in The Gray Sheet

Executive Summary

The Bush Administration took several steps last week in its agenda for improving public access to price and quality information on healthcare procedures, and some private insurers have followed suit

You may also be interested in...



Bush Medicare Proposal Would Require Price And Quality Transparency

The Bush administration continues to push its priorities of value-based purchasing and price transparency for health care consumers through legislation aimed at saving the Medicare program from insolvency

Bush Medicare Proposal Would Require Price And Quality Transparency

The Bush administration continues to push its priorities of value-based purchasing and price transparency for health care consumers through legislation aimed at saving the Medicare program from insolvency

Device Firms Would Have To Report Sales Prices To CMS Under Senate Bill

A bill introduced Oct. 23 in the Senate would require device makers seeking Medicare reimbursement to report to CMS the prices they negotiate with hospitals and other buyers for all implantable medical devices

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel